Updates to Microhematuria: AUA/SUFU Guideline (2025)
Daniel A. Barocas(Vanderbilt University Medical Center), Lesley Souter(Smiths Detection (Canada)), Yair Lotan(Southwestern Medical Center), Erin Kirkby(American Urological Association), Jay D. Raman(Penn State Milton S. Hershey Medical Center), Richard S. Matulewicz(Memorial Sloan Kettering Cancer Center), Lauren J. Pak(American Urological Association), Mary E. Westerman(The University of Texas MD Anderson Cancer Center)
Cited by 47
Related Papers
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592
Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
|The Journal of Urology|2012|487
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471